News & Events
-
Congressional Testimony 2008
Testimony of FDA officials before House and Senate Committees and Sub-committees.
-
September
- 09/25/2008
FDA's Role--Antimicrobial Resistance
Bernadette Dunham, D.V.M., Ph.D., before the House Committee on Agriculture, Subcommittee on Livestock, Dairy, and Poultry - 09/17/2008
FDA Food Protection Plan/Action Plan for Import Safety
David Acheson, M.D., F.R.C.P., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 09/17/2008
FDA Oversight of Direct-to-Consumer Advertising of Medical Devices
Daniel Schultz, M.D., before the Senate Special Committee on Aging
-
-
July
- 07/31/2008
Ongoing Investigation of Salmonella Saintpaul Outbreak
David Acheson, M.D., F.R.C.P., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 07/30/2008
Investigation of Salmonella Saintpaul Outbreak
David Acheson, M.D., F.R.C.P., before the House Committee on Agriculture, Subcommittee on Horticulture and Organic Agriculture - 07/09/2008
FDA's Role in Identifying and Communicating Drug Safety Issues
Paul Seligman, M.D., M.P.H., before the House Committee on Veterans' Affairs
-
-
June
- 06/24/2008
FDA's Role in Antimicrobial Resistance
Linda Tollefson, D.V.M., M.P.H., before the Senate Committee on Health, Education, Labor, and Pensions - 06/12/2008
Ongoing Efforts to Enhance Food Safety
David Acheson, M.D., F.R.C.P., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 06/10/2008
Bisphenol-A (BPA)
Norris Alderson, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Commerce, Trade and Consumer Protection - 06/05/2008
Reauthorization of ADUFA and the Proposed AGDUFA
Bernadette M. Dunham, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
-
-
May
- 05/14/2008
The Safety of Medical Products Regulated by FDA
Randall Lutter, Ph.D., before the House Committee on Oversight and Government Reform - 05/14/2008
BPA (Bisphenol-A)
Norris Alderson, Ph.D., before the Senate Committee on Commerce, Science, and Transportation, Subcommittee on Consumer Affairs, Insurance, and Automotive Safety - 05/14/2008
Discussion Draft of the "Food and Drug Administration Globalization Act" Legislation: Device and Cosmetic Safety
Stephen F. Sundlof, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 05/01/2008
Discussion Draft of the "Food and Drug Administration Globalization Act" Legislation: Drug Safety
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
-
-
April
- 04/29/2008
FDA’s Ongoing Heparin Investigation
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 04/25/2008
Chinese Seafood Imports
Don Kraemer, before the U.S. and China Economic and Security Review Commission - 04/24/2008
Food and Cosmetic Provisions of the "Food and Drug Administration Globalization Act" Discussion Draft Legislation
Stephen F. Sundlof, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 04/22/2008
Safety of Medical Products with Foreign Components
Andrew C. von Eschenbach, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 04/15/2008
Fiscal Year 2009 Budget Request
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 04/02/2008
Biologics Program--Funding
Jesse L. Goodman, M.D., M.P.H., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies
-
-
March
- 03/12/2008
Enhancing Food Safety
Stephen F. Sundlof, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
-
-
February
- 02/27/2008
Drug Safety--Funding
Janet Woodcock, M.D., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies
-
-
January
- 01/29/2008
Science at FDA
Andrew C. von Eschenbach, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
-
-
-